acivicin has been researched along with Glioblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, H; Gable, JE; Geier, EG; Giacomini, KM; Irwin, JJ; Sali, A; Schlessinger, A | 1 |
| Crowley, J; Eyre, HJ; Hynes, HE; Jaeckle, C; Pollock, TW; Stephens, RL; Taylor, SA | 1 |
1 trial(s) available for acivicin and Glioblastoma
| Article | Year |
|---|---|
Objective antitumor activity of acivicin in patients with recurrent CNS malignancies: a Southwest Oncology Group trial.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Drug Evaluation; Female; Glioblastoma; Humans; Isoxazoles; Magnetic Resonance Imaging; Male; Middle Aged; Recurrence; Tomography, X-Ray Computed; Vidarabine | 1991 |
1 other study(ies) available for acivicin and Glioblastoma
| Article | Year |
|---|---|
Structure-based ligand discovery for the Large-neutral Amino Acid Transporter 1, LAT-1.
Topics: Amines; Analysis of Variance; Blood-Brain Barrier; Cell Line, Tumor; Crystallography, X-Ray; Cyclohexanecarboxylic Acids; Drug Delivery Systems; Flow Cytometry; Gabapentin; gamma-Aminobutyric Acid; Glioblastoma; HEK293 Cells; Humans; Isoxazoles; Large Neutral Amino Acid-Transporter 1; Leucine; Ligands; Models, Molecular; Tritium | 2013 |